Many translated example sentences containing “eritropoyetina recombinante” – English-Spanish dictionary and search engine for English translations. La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes. The Pharmacokinetics of Recombinant. Efecto del tratamiento con eritropoyetina recombinante humana sobre la necesidad de transfusión sanguínea en los pacientes críticos. Effect of human.
|Published (Last):||22 March 2010|
|PDF File Size:||8.78 Mb|
|ePub File Size:||18.50 Mb|
|Price:||Free* [*Free Regsitration Required]|
New indications for erythropoietin in clinical practice. Their main characteristics are presented in Table 1. CiteScore measures average citations received per document published.
Continuing navigation will be considered as acceptance of this use. Are you a health professional able to prescribe or dispense drugs? Erythropoietin resistance and eriyropoyetina in non-dialysis patients with stage chronic kidney disease and heart disease.
Eritropoyetina Humana Recombinante Delta
Eur J Haematol ; El nivel de EPO en plasma previo a la dosis se sustrajo de todos los niveles que se obtuvieron tras administrarla. Investigation of the effects of editropoyetina receptor binding activity on the clearance of erythropoiesis-stimulating proteins: These findings need to be confirmed in a well-controlled study with a larger sample size in order to establish population pharmacokinetics of beta-Epo in BEN patients, to evaluate the effects of physiopathological factors on the disposition kinetics of beta-Epo and to find potential predictive factors for dosage individualization.
J Clin Pharmacol ; On the other hand, residual renal function was maintained longer in BEN patients than in those with other kidney diseases 34 and our BEN patients were shorter on hemodialysis treatment than non-BEN patients.
Universidad de Santiago de Compostela. This work is licensed under a Creative Commons Attribution 4.
Eritropoyetina recombinante humana en la insuficiencia renal crónica
Br J Clin Pharmacol ; SRJ is a prestige metric based on the idea that not all citations are the same. Complexo Hospitalario Universitario Juan Canalejo. Endemic nephropathy in Yugoslavia. Erythropoietin is reported as an ingredient of Eritropoyetina Humana Recombinante Delta in the following countries:.
To view content sources and attributions, please refer to our editorial policy.
Eritropoyetina Humana Recombinante Delta –
Results The study involved 24 hemodialysis patients, 10 patients with BEN and 14 with other kidney diseases, selected from 96 patients 40 BEN and eritopoyetina others who met the inclusion criteria. Our patients had iron reserves above the upper limit of normal and a similar proportion of subjects from each group used iron supplements.
Si continua navegando, consideramos que acepta su uso. The group with other kidney diseases consisted recombinanhe 8 patients with glomerulonephritis, 3 with hypertensive nephropathy, 2 with reflux nephropathy and 1 with polycystic kidney disease. For pharmacokinetic analysis the predose plasma level of Epo was subtracted from all postdose levels of Epo for each patient.
You can change the settings or obtain more information by clicking here. The pharmacokinetic parameters of Epo are presented in Table 3.
It should not be construed to indicate that the use of any medication in any recmobinante is eritropyoetina, appropriate or effective for you. A total of 24 subjects was selected from the population of hemodialysis patients according to the following inclusion criteria: Balkan endemic nephropathy BEN hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases.
The journal accepts submissions of articles in English and in Spanish languages. J Pharm Sci ; A number of factors may contribute to insufficient hematopoietic response to ESAs: SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
This item has received. Further information Always consult your healthcare provider to ensure the information displayed on this page applies to eritrppoyetina personal circumstances. July Pages